estrone has been researched along with Fibrous Dysplasia, Polyostotic in 5 studies
Hydroxyestrones: Estrone derivatives substituted with one or more hydroxyl groups in any position. They are important metabolites of estrone and other estrogens.
Fibrous Dysplasia, Polyostotic: FIBROUS DYSPLASIA OF BONE affecting several bones. When melanotic pigmentation (CAFE-AU-LAIT SPOTS) and multiple endocrine hyperfunction are additionally associated it is referred to as Albright syndrome.
Excerpt | Relevance | Reference |
---|---|---|
"We undertook a 1-year multicenter trial of tamoxifen treatment for precocious puberty in girls with McCune-Albright syndrome (MAS)." | 9.10 | Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial. ( Eugster, EA; Jou, HC; Pescovitz, OH; Plourde, P; Reiter, EO; Rubin, SD, 2003) |
"We administered the aromatase inhibitor fadrozole to 16 girls with gonadotropin-independent precocious puberty due to the McCune-Albright syndrome." | 7.72 | Lack of efficacy of fadrozole in treating precocious puberty in girls with the McCune-Albright syndrome. ( Calis, K; Cutler, GB; Feuillan, PP; Jones, J; Nunez, SB, 2003) |
"The McCune-Albright syndrome is characterized by café au lait spots, fibrous dysplasia of bones, and sexual precocity." | 5.27 | Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone. ( Barnes, K; Cutler, GB; Dwyer, A; Feuillan, PP; Foster, CM; Hench, KD; Loriaux, DL; Malley, JD; Pescovitz, OH; Shawker, T, 1986) |
"We undertook a 1-year multicenter trial of tamoxifen treatment for precocious puberty in girls with McCune-Albright syndrome (MAS)." | 5.10 | Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial. ( Eugster, EA; Jou, HC; Pescovitz, OH; Plourde, P; Reiter, EO; Rubin, SD, 2003) |
"We administered the aromatase inhibitor fadrozole to 16 girls with gonadotropin-independent precocious puberty due to the McCune-Albright syndrome." | 3.72 | Lack of efficacy of fadrozole in treating precocious puberty in girls with the McCune-Albright syndrome. ( Calis, K; Cutler, GB; Feuillan, PP; Jones, J; Nunez, SB, 2003) |
"Precocious puberty in girls with McCune-Albright syndrome has been attributed in some cases to early activation of the hypothalamic-pituitary-gonadal axis and in other cases to sex steroid secretion by apparently autonomous ovarian cysts." | 1.27 | Absence of pubertal gonadotropin secretion in girls with McCune-Albright syndrome. ( Comite, F; Cutler, GB; Foster, CM; Loriaux, DL; Pescovitz, OH; Ross, JL; Shawker, T, 1984) |
"The McCune-Albright syndrome is characterized by café au lait spots, fibrous dysplasia of bones, and sexual precocity." | 1.27 | Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone. ( Barnes, K; Cutler, GB; Dwyer, A; Feuillan, PP; Foster, CM; Hench, KD; Loriaux, DL; Malley, JD; Pescovitz, OH; Shawker, T, 1986) |
"The sexual precocity of polyostotic fibrous dysplasia is occasionally accompanied by other endocrine disorders, but in only two previous instances has Cushing syndrome been reported." | 1.25 | Cushing syndrome, sexual precocity, and polyostotic fibrous dysplasia (Albright syndrome) in infancy. ( Crawford, JD; Danon, M; Kim, S; Robboy, SJ; Scully, R, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eugster, EA | 1 |
Rubin, SD | 1 |
Reiter, EO | 1 |
Plourde, P | 1 |
Jou, HC | 1 |
Pescovitz, OH | 3 |
Nunez, SB | 1 |
Calis, K | 1 |
Cutler, GB | 3 |
Jones, J | 1 |
Feuillan, PP | 2 |
Foster, CM | 2 |
Ross, JL | 1 |
Shawker, T | 2 |
Loriaux, DL | 2 |
Comite, F | 1 |
Danon, M | 1 |
Robboy, SJ | 1 |
Kim, S | 1 |
Scully, R | 1 |
Crawford, JD | 1 |
Hench, KD | 1 |
Dwyer, A | 1 |
Malley, JD | 1 |
Barnes, K | 1 |
1 trial available for estrone and Fibrous Dysplasia, Polyostotic
Article | Year |
---|---|
Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial.
Topics: Cafe-au-Lait Spots; Estradiol; Estrogen Antagonists; Estrone; Female; Fibrous Dysplasia of Bone; Fib | 2003 |
4 other studies available for estrone and Fibrous Dysplasia, Polyostotic
Article | Year |
---|---|
Lack of efficacy of fadrozole in treating precocious puberty in girls with the McCune-Albright syndrome.
Topics: Age Determination by Skeleton; Aging; Aromatase Inhibitors; Child; Child, Preschool; Drug Therapy, C | 2003 |
Absence of pubertal gonadotropin secretion in girls with McCune-Albright syndrome.
Topics: Adolescent; Child; Child, Preschool; Estradiol; Estrone; Female; Fibrous Dysplasia of Bone; Fibrous | 1984 |
Cushing syndrome, sexual precocity, and polyostotic fibrous dysplasia (Albright syndrome) in infancy.
Topics: Adrenal Glands; Adrenalectomy; Adrenocorticotropic Hormone; Cushing Syndrome; Estradiol; Estrone; Fe | 1975 |
Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone.
Topics: Aromatase Inhibitors; Bone Development; Child, Preschool; Estradiol; Estrone; Female; Fibrous Dyspla | 1986 |